DRREDDY — Dr Reddys Laboratories Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Dr Reddys Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	30,614	60,485	72,010	76,795	53,927
Depreciation
Non-Cash Items	7,102	4,457	-1,048	2,578	6,494
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-21,260	-18,569	-40,229	-49,982	-24,272
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	28,108	58,875	45,433	46,428	56,737
Capital Expenditures	-19,049	-18,866	-27,435	-34,398	-38,405
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7,338	-22,507	-12,848	-23,679	-27,088
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-26,387	-41,373	-40,283	-58,077	-65,493
Financing Cash Flow Items	-1,345	-1,853	-2,266	3,573	-4,441
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-2,422	-26,861	-3,763	18,911	8,290
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	32	-9,073	1,328	7,486	775